ESPR
Esperion Therapeutics Inc
Price:  
2.89 
USD
Volume:  
7,267,847.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ESPR Fair Value

-179.01 %
Upside

As of 2024-06-13, the Fair Value of Esperion Therapeutics Inc (ESPR) is -2.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.89 USD, the upside of Esperion Therapeutics Inc is -179.01%.

Note: valuation result may not be accurate due to the company's negative EPS.

2.89 USD
Stock Price
-2.28 USD
Fair Price
FAIR VALUE CALCULATION

ESPR Fair Value

Peter Lynch's formula is:

ESPR Fair Value
= Earnings Growth Rate x TTM EPS
ESPR Fair Value
= 5.00 x -0.46
ESPR Fair Value
= -2.28

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -97.20 -143.60 -269.10 -233.70 -209.25 -190.57
YoY growth 51.83% -47.74% -87.40% 13.15% 10.46% -11.94%

ESPR Fair Value - Key Data

Market Cap (mil) 547.54
P/E
Forward P/E
EPS -0.46
Avg earnings growth rate -11.94%
TTM earnings -86.52